Fritextsökning
Innehållstyper
-
CTC Clinical Trial Consultants AB
-
Anna Törner: The clinical trial – Periscope to reality
What happens to the patients in the clinical trial is not very interesting, writes Anna Törner in a column.
-
The new ZEISS Celldiscoverer 7 has been launched
Adaptable automation for advanced workflows.
-
The Swedish Academy of Sciences: “We have too many researchers”
Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.
-
ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics
Live imaging with uniform super-resolution in all spatial dimensions.
-
Explore our tailored program for Control 2025
Choose an innovation tour, or join our industry-specific guided tours.
-
Study names with an attitude – more important than you might think
Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.
-
TECHNIA AB
-
“I am driven by the desire to develop a product that can be sold worldwide”
Ranked number one in the world by the WHO in diarrhoea research and soon in phase III studies for its vaccine candidate – Scandinavian Biopharma is rushing forw...
-
Unmatched performance and flexibility in its class
The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.
-
Magnus Gisslén lämnar Folkhälsomyndigheten: ”Blev obekvämt”
Statsepidemiologen Magnus Gisslén slutar på Folkhälsomyndigheten och riktar samtidigt hård kritik mot myndigheten.
-
CT technology for when the inside matters
ZEISS METROTOM 1 now at #HandsOnMetrology.
-
Precision medicine centre: “Extensive activity on several fronts”
Two years ago, the Karolinska Institutet and the Karolinska University Hospital announced that they would jointly launch the Precision Medicine Centre. Medtech ...
-
ZEISS unveils AI-powered Research Data Platform
Collaboration with Boehringer Ingelheim champions the future of personalized eye care.
-
Enabling 3D Multiplexing Spatial Omics Workflows in Neuroscience
Case study by ZEISS Microscopy.
-
Failed to read the fine print – lost his life’s work
A celebrated CEO and co-founder of a pioneering lab company one moment – the next, fired, kicked out and written out of the company’s history. This is the story...
-
Study: Popular diabetes drug may be effective against liver disease
After its success in diabetes and weight loss, a new potential therapeutic area has been identified for Ozempic and other GLP1 analogues. A new study links the ...
-
The future of healthcare in focus: ”Together, things happen”
In march, it’s once again time for Fokus Patient, an event for the industry where the patients’ perspective takes center stage. It’s a great way to spread knowl...
-
ALS – When the body has given up, but the brain persists
The nerve disease ALS gradually deprives the patient of control over the muscles and, eventually, also of speech. The eyes continue to function, though, and wit...
-
Column: ”Authentic leadership and clear mandates pave the way for more female CEOs”
”I believe that the aspect of having clear mandates and titles on the one hand and women progressing into top positions must be explored further”, Helena Strigå...
-
Join us for a Life Science seminar on april 9th on GoCo
Festo products and solutions are setting the stage for better health through innovative solutions for reliable medical technology and precise, reproducible labo...
-
Business Sweden: “Companies have a lot to offer in data-driven precision medicine”
Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.
-
Medical Plastics Tips & Tricks
Measuringhero video by ZEISS.
-
Raised millions to develop a treatment for ´butterfly children´
Fragile as a butterfly’s wing – that’s how people living with Epidermolysis Bullosa are usually described. The Lund-based company Xinnate recently raised SEK 10...